Information Provided By:
Fly News Breaks for March 16, 2016
HCP
Mar 16, 2016 | 05:52 EDT
UBS analyst Nick Yulico downgraded HCP to Neutral saying the valuation looks less compelling following his analysis of CMS data. The data on therapy minutes point to potential additional headwinds for HCP's largest tenant, HCR ManorCare, the analyst contends. He keeps a $31 price target for the shares.